1-12 of 12
Ross D Brown, PhD
Close
Sort by
Journal Articles

Protective Cytotoxic Clonal T-Cells in Myeloma Have the Characteristics of Telomere-Independent Senescence Rather Than an Exhausted or Anergic Phenotype: Implications for Immunotherapy

Hayley Suen, BSc (Hons), Douglas E Joshua, MBBS DPhil, Ross D Brown, PhD, Shihong Yang, MSc, Pasquale Mario Barbaro, MBBS, P Joy Ho, MBBS DPhil, John Gibson, MBBS PhD
Journal: Blood
Blood (2014) 124 (21): 3367.
https://doi.org/10.1182/blood.V124.21.3367.3367
Published: 2014
Journal Articles

Ten Year Survival in Patients with Myeloma Is Characterized by the Persistence of Immunological Control Which Is Detected by Immunological Biomarkers

Ross D Brown, PhD, Hayley Suen, BSc (Hons), Christian E Bryant, MBBS, Shihong Yang, MSc, James Favaloro, BSc, John Gibson, MBBS PhD, P Joy Ho, MBBS, DPhil, Phillip Fromm, PhD, Derek NJ Hart, MBCHB, DPhil, Douglas E Joshua, MBBS, DPhil
Journal: Blood
Blood (2012) 120 (21): 1818.
https://doi.org/10.1182/blood.V120.21.1818.1818
Published: 2012
Journal Articles

Blockade of the Hedgehog Signaling Pathway by the Novel Agent NVP-LDE225 Induces Differentiation, Prevents De-Differentiation and Inhibits Proliferation of Multiple Myeloma Stem Cells in Vitro

Shihong Yang, MSc, Ross D Brown, PhD, Yen S Loh, PhD, Hayley Suen, BSc (Hons), James Favaloro, BSc, John Gibson, MBBS, PhD, Phoebe Joy Ho, MBBS, DPhil, Douglas E Joshua, MBBS, DPhil
Journal: Blood
Blood (2012) 120 (21): 3950.
https://doi.org/10.1182/blood.V120.21.3950.3950
Published: 2012
Journal Articles

HLA-G and CD86 Expression on Malignant Plasma Cells Convey a Poor Prognosis and Immunoregulate T Cells In Patients with Myeloma

Ross D. Brown, PhD, Karieshma Kabani, Shihong Yang, Esther Aklilu, Phoebe Joy Ho, MBBS, John Gibson, MBBS, Douglas E. Joshua, MBBS, DPhil
Journal: Blood
Blood (2010) 116 (21): 983.
https://doi.org/10.1182/blood.V116.21.983.983
Published: 2010
Journal Articles

The Investigation of Mechanisms Underlying Hoechst 33342 Efflux in Myeloma ‘Side Population' Cells.

Yen Siew Loh, PhD, John D Allen, PhD, Ammira Al-shabeeb, PhD, Ross D. Brown, PhD, MBA, Jia Li, Joshua Douglas, Professor, Daniel Sze, A/Professor
Journal: Blood
Blood (2009) 114 (22): 2759.
https://doi.org/10.1182/blood.V114.22.2759.2759
Published: 2009
Journal Articles

Trogocytosis in Multiple Myeloma.

Ross D. Brown, PhD, MBA, Karieshma Kabani, BSc, Shihong Yang, MSc, Aklilu Esther, BSc, Phoebe Joy Ho, MBBS, DPhil, John Gibson, MBBS, PhD, Douglas E. Joshua, MBBS, DPhil
Journal: Blood
Blood (2008) 112 (11): 1681.
https://doi.org/10.1182/blood.V112.11.1681.1681
Published: 2008
Journal Articles

Differentiation of Multiple Myeloma and MGUS by Cross Validated Differential Proteomic Analysis.

Ross D. Brown, PhD, Larissa Belov, PhD, Cris dos Remedios, PhD, Daniel Sze, PhD, Simon Cooper, Mila Dolotin, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2006) 108 (11): 3524.
https://doi.org/10.1182/blood.V108.11.3524.3524
Published: 2006
Journal Articles

Gene Expression Profiling of the Clinical Significant CD57 + CD8 + Cytotoxic T Cell Expansions in Patients with Waldenstrom’s Macroglobulinemia.

Daniel Sze, PhD, Tetsuo Yamagishi, BSc, Warren Kaplan, PhD, Ross D. Brown, PhD, Phoebe Joy Ho, MD, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2006) 108 (11): 3395.
https://doi.org/10.1182/blood.V108.11.3395.3395
Published: 2006
Journal Articles

Identification and Characterization of Cancer Stem Cells in Multiple Myeloma.

Daniel Sze, PhD, Yen S. Loh, BSc, Suilin Mo, MSc, Warren Kaplan, PhD, Ross D. Brown, PhD, Phoebe Joy Ho, MD, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2006) 108 (11): 512.
https://doi.org/10.1182/blood.V108.11.512.512
Published: 2006
Journal Articles

The Immunomodulatory Action of Thalidomide in Patients with Multiple Myeloma Involves a Clonal Expansion of Late-Differentiated Cytotoxic Effector Cells.

Ross D. Brown, PhD, Allan Murray, Daniel M. Sze, PhD, Andrew Spencer, MD, Phoebe Joy Ho, MD, John Gibson, MD, Douglas E. Joshua, MD
Journal: Blood
Blood (2005) 106 (11): 5108.
https://doi.org/10.1182/blood.V106.11.5108.5108
Published: 2005
Journal Articles

Gene Expression Profiles of the Clinically Significant "Late" Stage Expanded Cytotoxic T Cells in Myeloma.

Tetsuo Yamagishi, BSc, Warren Kaplan, PhD, Devanshi Seth, PhD, Shihong Yang, MMed, Xin An, PhD, Ross D. Brown, PhD, Joy Ho, MBBS, John Gibson, MBBS, Douglas E. Joshua, MBBS, Daniel M. Sze, PhD
Journal: Blood
Blood (2005) 106 (11): 3418.
https://doi.org/10.1182/blood.V106.11.3418.3418
Published: 2005
Journal Articles

Development of Retargeted CD38-Specific NK-92 Cell Line for Potential Anti-Myeloma Immunotherapy.

Shihong Yang, MMed, Xin An, PhD, Ross D. Brown, PhD, Joy Ho, PhD, John Gibson, PhD, Douglas E. Joshua, PhD, Winfried Wels, PhD, Daniel M. Sze, PhD
Journal: Blood
Blood (2005) 106 (11): 5104.
https://doi.org/10.1182/blood.V106.11.5104.5104
Published: 2005